m+Medelevator.RU
← Поиск публикаций
Nature neuroscience · 2025

Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer's disease.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ardura-Fabregat Alberto, Bosch Lance Fredrick Pahutan, Wogram Emile, Mossad Omar, Sankowski Roman, Aktories Philipp, Kieger Lina, Cook James, Hasavci Dilara, Ulupinar Hatice, Brock Daniel, Wang Fang, Iovino Nicola, Wald Samuel, Preissl Sebastian, Yilmaz Bahtiyar, Schnepf Daniel, Macpherson Andrew J, Blank Thomas, Kierdorf Katrin, Prinz Marco

Аннотация

Microglial spatial heterogeneity remains a crucial yet not fully answered question in the context of potential cell-directed therapies for Alzheimer's disease (AD). There is an unclear understanding of the dynamics of distinct microglia states adjacent to or far from amyloid-beta (Aβ) plaques and their contributions to neurodegenerative diseases. Here we combine multicolor fluorescence cell fate mapping, single-cell transcriptional analysis, epigenetic profiling, immunohistochemistry and computational modeling to comprehensively characterize the relation of plaque-associated microglia (PAM) and non-plaque-associated microglia (non-PAM) in a mouse model of AD. We show that non-PAM are a distinct and highly dynamic microglial state, transitioning to PAM after Aβ plaque deposition in female mice. Non-PAM modulate the cell population expansion in response to amyloid deposition and rapidly respond to environmental cues. Indeed, Csf1 signaling modulates non-PAM-to-PAM transition during disease progression. Our data suggest that microglia states and their dynamics between each other can have distinct contributions to disease, and they may be targeted for the treatment of AD.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты